TrialHaematologica2015

Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.

Jesus F San Miguel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.